Covid-19 Research

Case Report

Therapeutic Effects of Bone Marrow Aspirate Concentrate Prepared with NovaStem Kit in Patients with Degenerative Knee Osteoarthritis: An Interim Analysis of a Retrospective Case Series

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Case Report
Subject Medicine Group
OCLC JBRES Record
Jekyun Kim MD, Ji Young Seok, In kyung Sohn, Seok Cheol Lee, Bong-geun Shin, Dongsoo Kim PhD*
Issue: Volume7-Issue3
Pages: 1-8
Received: 2026-01-05
Accepted: 2026-03-24
Published: 2026-03-25

Abstract

Background: Degenerative Knee Osteoarthritis (KOA) is a major cause of pain and disability, and effective joint-preserving therapies for moderate (Kellgren-Lawrence [KL] grade 2-3) disease remain limited. Bone Marrow Aspirate Concentrate (BMAC) has emerged as a regenerative treatment option, and intra-articular BMAC injection for KOA was recently approved in Korea through the New Health Technology Assessment (NHTA). However, real clinical evidence in the Korean population remains limited. This study provides early real-world clinical evidence of BMAC therapy in a routine clinical setting
Methods: This study is an interim analysis of an ongoing retrospective observational case series (target n = 62) conducted at a single orthopedic center. Eleven consecutive patients with Kellgren-Lawrence (KL) grade 2-3 KOA who failed conservative treatment were included between January 2024 and 2025. All patients (2 males, 9 females; mean age 58.55 ± 5.85 years) received a single intra-articular injection of autologous BMAC prepared using the NovaStem system. The primary endpoint was the change in Visual Analog Scale (VAS) score at 1 day post-procedure (discharge). Secondary observations included follow-up outcomes at 1, 3, 6, and 12 months. Pain severity was assessed using VAS at baseline and at 1 day post-procedure (discharge). Pre- and post-treatment VAS scores were compared using a paired t-test following assessment of normality, with significance set at p < 0.05. Patients were followed up for up to 12 months to determine whether there was any improvement in pain or adverse reactions.
Results: The mean baseline VAS score significantly decreased from 5.00 ± 0.63 to 2.82 ± 0.60 at the post-treatment (mean difference, 2.18; 95% CI, 1.63-2.73; p < 0.0001). A clinically meaningful improvement (?2-point VAS reduction) was observed in 81.8% (9/11) of patients. This reduction exceeded the established minimal clinically important difference for KOA. No serious adverse events were reported. Limited follow-up data suggested variable durability, with some patients requiring additional surgical intervention.
Conclusion: Intra-articular BMAC injection using the NovaStem system demonstrated significant short-term pain reduction in patients with moderate KOA in our clinical setting. Intra-articular BMAC injection appears to be a safe and suggests a potential role as a joint-preserving option for patients with KL grade 2–3 knee OA who have not responded to conservative care. These findings represent early clinical evidence following NHTA approval, providing in vivo evidence supporting BMAC as a novel regenerative therapy in orthopedic practice. Larger cohort analysis and longer-term follow-up are needed to confirm durability and functional outcomes.

FullText HTML FullText PDF DOI: 10.37871/jbres2282 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2026 Jekyun Kim MD, et al. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Jekyun Kim MD, Seok JY, Sohn Ik, Lee SC, Bong-geun S, Kim D. Therapeutic Effects of Bone Marrow Aspirate Concentrate Prepared with NovaStem Kit in Patients with Degenerative Knee Osteoarthritis: An Interim Analysis of a Retrospective Case Series. J Biomed Res Environ Sci. 2026 Mar 25; 7(3): 8. Doi: 10.37872/jbres2282

Subject area(s)

Orthopedics

References

  1. Allen KD, Thoma LM, Golightly YM. Epidemiology of osteoarthritis. Osteoarthritis Cartilage. 2022 Feb;30(2):184-195. doi: 10.1016/j.joca.2021.04.020. Epub 2021 Sep 14. PMID: 34534661; PMCID: PMC10735233.
  2. Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, Callahan L, Copenhaver C, Dodge C, Felson D, Gellar K, Harvey WF, Hawker G, Herzig E, Kwoh CK, Nelson AE, Samuels J, Scanzello C, White D, Wise B, Altman RD, DiRenzo D, Fontanarosa J, Giradi G, Ishimori M, Misra D, Shah AA, Shmagel AK, Thoma LM, Turgunbaev M, Turner AS, Reston J. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res (Hoboken). 2020 Feb;72(2):149-162. doi: 10.1002/acr.24131. Epub 2020 Jan 6. Erratum in: Arthritis Care Res (Hoboken). 2021 May;73(5):764. doi: 10.1002/acr.24615. PMID: 31908149; PMCID: PMC11488261.
  3. Jones DF, Hodgden JD, Onarecker CD. In adults with osteoarthritis of the knee, is conservative management more effective than intra-articular corticosteroid injections in relieving pain? J Okla State Med Assoc. 2018 Aug-Sep;111(7):712-713. PMID: 30524147; PMCID: PMC6279239.
  4. Cook CS, Smith PA. Clinical Update: Why PRP Should Be Your First Choice for Injection Therapy in Treating Osteoarthritis of the Knee. Curr Rev Musculoskelet Med. 2018 Dec;11(4):583-592. doi: 10.1007/s12178-018-9524-x. PMID: 30350299; PMCID: PMC6220006.
  5. DeJulius CR, Gulati S, Hasty KA, Crofford LJ, Duvall CL. Recent Advances in Clinical Translation of Intra-Articular Osteoarthritis Drug Delivery Systems. Adv Ther (Weinh). 2021 Jan;4(1):2000088. doi: 10.1002/adtp.202000088. Epub 2020 Sep 28. PMID: 33709019; PMCID: PMC7941755.
  6. McCarrel T, Fortier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res. 2009 Aug;27(8):1033-42. doi: 10.1002/jor.20853. PMID: 19170097.
  7. Park D, Koh HS, Choi YH, Park I. Bone Marrow Aspirate Concentrate (BMAC) for Knee Osteoarthritis: A Narrative Review of Clinical Efficacy and Future Directions. Medicina (Kaunas). 2025 May 6;61(5):853. doi: 10.3390/medicina61050853. PMID: 40428811; PMCID: PMC12113016.
  8. Kim GB, Seo MS, Park WT, Lee GW. Bone Marrow Aspirate Concentrate: Its Uses in Osteoarthritis. Int J Mol Sci. 2020 May 2;21(9):3224. doi: 10.3390/ijms21093224. PMID: 32370163; PMCID: PMC7247342.
  9. Shin S, Kim Y, Choi J, Park JY; Health Technology Reassessment Committee. Deliberative process of health technology reassessment by health technology assessment agency in Korea. Int J Technol Assess Health Care. 2024 May 13;40(1):e28. doi: 10.1017/S026646232400014X. PMID: 38738417; PMCID: PMC11569900.
  10. Kang J, Kim J, Shin C-M, Park B. An investigation of the current status of the new Health Technology Assessment in Korea and factors influencing assessment results. Journal of the Korean Medical Association/Taehan Uisa Hyophoe Chi. 2024;67(1).
  11. Bennell KL, Paterson KL, Metcalf BR, Duong V, Eyles J, Kasza J, Wang Y, Cicuttini F, Buchbinder R, Forbes A, Harris A, Yu SP, Connell D, Linklater J, Wang BH, Oo WM, Hunter DJ. Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial. JAMA. 2021 Nov 23;326(20):2021-2030. doi: 10.1001/jama.2021.19415. PMID: 34812863; PMCID: PMC8611484.
  12. Lee MS, Lee HW. Current status of health technology assessment in Korean medicine. Evidence-Based Chinese Medicine And Technology Assessment ??????????: Tsinghua University Press. 2025.
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership